
    
      For locally advanced nasopharyngeal carcinoma patients(UICC7th stageIII to IVb),the
      investigators randomised assign to either 3 cycles of cisplatin plus 5-fluorouracil plus (PF)
      or 3 cycles of docetaxel plus cisplatin and 5-fluorouracil(TPF) neoadjuvant chemotherapy. 21
      days a cycle.

      After the neoadjuvant chemotherapy ,the patients will receive the intensity modulated
      radiotherapy(IMRT) with 2 cycles of concurrent chemotherapy of cisplatin 80mg/m2.
    
  